Source comparison
MOTS-c 5-Amino-1MQ Stack Protocol: Research Design Comparison
The table below compares three common research designs for the MOTS-c 5-amino-1MQ stack protocol, highlighting dosing frequency, timing, cycle length, and practical considerations for different study objectives. | Protocol Design | MOTS-c Dosing | 5-Amino-1MQ
This comparison does not assign a generated winner or score.
- The table below compares three common research designs for the MOTS-c 5-amino-1MQ stack protocol, highlighting dosing frequency, timing, cycle length, and practical considerations for different study objectives.
- | Protocol Design | MOTS-c Dosing | 5-Amino-1MQ Dosing | Timing Strategy | Cycle Length | Best Suited For | Professional Assessment ||—|—|—|—|—|—|| Standard Metabolic Stack | 10mg subcutaneous, 3x/week (Mon/Wed/Fri) | 100mg oral, daily | MOTS-c AM fasted; 5-Amino-1MQ PM | 8–12 weeks on, 4–6 weeks off | General metabolic research, fat oxidation studies, insulin sensitivity protocols | Most balanced approach. Aligns AMPK activation with circadian peaks and maintains NAD+ elevation across 24-hour cycles. Lowest error rate in administration. || Intensive Performance Protocol | 10mg subcutaneous, 5x/week (weekdays) | 150mg oral, daily | Both compounds AM, pre-training | 6 weeks on, 4 weeks off | Athletic performance research, substrate utilization studies, endurance capacity trials | Higher dosing frequency and dose intensity produce more pronounced short-term shifts in RER and VO2 max, but require stricter adherence and increase washout sensitivity. || Extended Low-Dose Research | 5mg subc
- The standard metabolic stack remains the most widely adopted design in published research because it balances efficacy with practical adherence. Splitting MOTS-c and 5-amino-1MQ dosing times—morning and evening—extends metabolic signaling across the full day, while the 3x/week MOTS-c schedule aligns with training sessions in most protocols. Intensive performance protocols are reserved for short-term studies focused on acute performance markers like substrate oxidation or mitochondrial respiration, where higher frequency justifies the added complexity. Extended low-dose designs suit aging or longevity research where the objective is sustained metabolic improvement over months rather than weeks.